SynapCell
Created in 2005
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
218 3,784Activities
Technologies
Entity types
Location
Chem. des Prêles, 38330 Saint-Ismier, France
Saint-Ismier
France
Employees
Scale: 11-50
Estimated: 40
SIREN
481563526Engaged corporates
11
5 7Added in Motherbase
4 years, 9 months ago
biotech Value proposition
We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG
SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such as schizophrenia.
Since 2005, our returning customers in USA, Japan, Korea or Europe helped the company establish a unique reputation on the market and is the basis for long-lasting successful business partnerships.
Drug discovery solutions, Central Nervous System, Integrated electrophysiology, EEG biomarkers, Rodent models, Translational, brain, Innovation & services, Predictive Biomarkers, CRO, Contract Research Organization, pharmaco-EEG, Epilepsy, Parkinson, Pharmaco-resistant epilepsy, MTLE, GAERS, AERP, Biomarker, Tremor, neural network, oscillations, and Preclinical CNS CROOriginal language
We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG
SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such as schizophrenia.
Since 2005, our returning customers in USA, Japan, Korea or Europe helped the company establish a unique reputation on the market and is the basis for long-lasting successful business partnerships.
Preclinical EEG CRO for CNS drug discovery | SynapCell
Partner with SynapCell, the leading CRO in preclinical EEG for CNS drug discovery. Specialized in epilepsy, psychiatric, and rare disorders.
https://synapcell.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 UCB Pharmaceutical Manufacturing | UCB Pharmaceutical Manufacturing | Other 30 Sep 2024 | | |
 Réseau Entreprendre Alsace Startup accelerator & VC | Réseau Entreprendre Alsace Startup accelerator & VC | Other 12 Jun 2024 | | |
 inovallée, Grenoble Alpes Technopole NGO, Think Tank, Business Consulting and Services | inovallée, Grenoble Alpes Technopole NGO, Think Tank, Business Consulting and Services | Other 5 Oct 2024 | | |
 Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Other 6 Jul 2023 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 5 Jul 2024 | | |
 Grenoble Alpes National and local authorities, Public Relations and Communications Services | Grenoble Alpes National and local authorities, Public Relations and Communications Services | Other 4 Jun 2023 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Not capitalistic Partnership Event 16 Oct 2018 | | |
 Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 28 Mar 2019 | | |
 MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Not capitalistic Not partnership Event 19 Jul 2024 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 15 Oct 2019 30 Sep 2023 | | |